Abstract: The present invention relates to a novel Bifidobacterium bifidum MG731 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Bifidobacterium bifidum MG731 strain of the present invention has effects of inhibiting the proliferation of cancer cells, decreasing the mobility of cancer cells, inhibiting the neoangiogenesis, and increasing the anticancer immune response as well as reducing the expression of inflammatory factors, thereby having effects of preventing or treating cancers or inflammatory diseases. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Bifidobacterium bifidum MG731 strain of the present invention exhibits a better anticancer effect. In addition, the present invention relates to a novel Lactococcus lactis GEN3033 strain and a composition for preventing or treating cancers, comprising the same.

Abstract: A method for separating polybutene, the method including: (1) introducing a polybutene solution into a distillation column, the solution including polybutene, a halogenated hydrocarbon solvent, and a non-polar hydrocarbon solvent and having a viscosity of 1 cp to 50 cp measured at 25° C. using a rotational viscometer; (2) collecting an upper stream including the halogenated hydrocarbon solvent and a portion of the non-polar hydrocarbon solvent from an upper portion of the distillation column, and collecting a lower stream including the polybutene and a remaining portion of the non-polar hydrocarbon solvent from a lower portion of the distillation column, where the lower stream has a viscosity of 10 cp to 150 cp; and (3) separating the remaining portion of the non-polar hydrocarbon solvent and the polybutene from the lower stream.

Abstract: The present invention relates to a method for fabricating an implant, comprising: (a) acquiring patient medical imaging data to define the appearance prior to the implant's insertion and a seating surface where the implant is seated, (b) acquiring a virtual image data defining the appearance after the implant's insertion, and (c) designing the implant based on the acquired patient medical imaging data and the virtual imaging data, wherein, the step of (c) includes determining a shape and height of the implant based on a difference between an appearance prior to the implant's insertion and an appearance after the implant's insertion, based on a seating surface defined from the acquired patient medical imaging data. This allows for a more comfortable fit of the implant to the nasal bone and cartilage, while achieving a post-operative appearance that is consistent with the intentions of the surgeon and patient.

Abstract: Provided is a hybrid drive device including a main power source; an auxiliary power source; a main deformation part configured to be deformable in response to receiving a voltage from the main power source; and an auxiliary deformation part configured to connect to the main deformation part and to be deformable in response to receiving a voltage from the auxiliary power source.

Abstract: The present invention relates to a use of a pharmaceutical composition which includes a carbamate compound of chemical formula 1 and is administered to prevent, alleviate, or treat tremors or tremor syndrome.

Abstract: Provided is a hybrid drive device including a main power source; an auxiliary power source; a main deformation part configured to be deformable in response to receiving a voltage from the main power source; and an auxiliary deformation part configured to connect to the main deformation part and to be deformable in response to receiving a voltage from the auxiliary power source.

Abstract: The present invention provides a pharmaceutical composition for preventing or treating macular degeneration, which comprises benzopyran derivatives substituted with secondary amines including imidazole or pharmaceutically acceptable salts thereof as an active ingredient. The pharmaceutical composition of the present invention may be used in the form of eye drops.

Abstract: The present invention relates to a use of a pharmaceutical composition which includes a carbamate compound of chemical formula 1 and is administered to prevent, alleviate, or treat tremors or tremor syndrome.

Abstract: The present invention provides a pharmaceutical composition for preventing or treating macular degeneration, which comprises benzopyran derivatives substituted with secondary amines including imidazole or pharmaceutically acceptable salts thereof as an active ingredient. The pharmaceutical composition of the present invention may be used in the form of eye drops.

Abstract: Provided herein is a mutant microorganism containing a methylmalonyl-CoA reductase-encoding gene having an activity of converting methylmalonyl-CoA to methylmalonate semialdehyde and uses of the mutant microorganism. The mutant microorganism includes a gene encoding kingdom Archaea-derived methylmalonyl-CoA reductase.

Abstract: Provided is a glass composition for a ceramic phosphor plate, including: 75 to 85 mol % of an oxide mixture composed of SiO2, B2O3 and ZnO; 10 to 15 mol % of at least one carbonate compound including an alkali metal; and 1 to 5 mol % of Al2O3, wherein a content of B2O3 is less than 25 mol %.

Abstract: Provided are a novel derivative of 5-carbamoyl adamantan-2-yl amide of Formula (I), or a pharmaceutically acceptable salt thereof, and a pharmaceutical use thereof for inhibiting the activity of 11?-hydroxystreroid dehydrogenase type 1 (11b-HSD1) or for preventing and/or treating various diseases mediated by 11?-hydroxystreroid dehydrogenase type 1.

Abstract: Provided is a glass composition for a ceramic phosphor plate, including: 75 to 85 mol % of an oxide mixture composed of SiO2, B2O3 and ZnO; 10 to 15 mol % of at least one carbonate compound including an alkali metal; and 1 to 5 mol % of Al2O3, wherein a content of B2O3 is less than 25 mol %.

Abstract: Provided are a novel derivative of 5-carbamoyl adamantan-2-yl amide or a pharmaceutically acceptable salt thereof, and a pharmaceutical use thereof for inhibiting the activity of 11?-hydroxystreroid dehydrogenase type 1 (11b-HSD1) or for preventing and/or treating various diseases mediated by 11?-hydroxystreroid dehydrogenase type 1.

Abstract: The present invention provides a pharmaceutical composition for preventing or treating macular degeneration, which comprises benzopyran derivatives substituted with secondary amines including imidazole or pharmaceutically acceptable salts thereof as an active ingredient. The pharmaceutical composition of the present invention may be used in the form of eye drops.

Abstract: The present invention relates to a composition for promoting memory or learning ability and to a composition for preventing and treating cognitive impairment, which comprise one, two or more plant extracts selected from the group consisting of Artemisia apiaceae extract, Illicium verum extract and Lepidium apefalum extract. The present invention has the effect of inhibiting neural cell damage, especially, neural cells of the basal part of the cerebrum by inhibiting acetylcholinesterase activity and through antioxidative activity (for example, inhibiting the generation of oxidative reactive species) and affinity for an NMDA receptor. The compositions of the present invention may have the effect of not only promoting memory or learning ability by protecting neural cells and preventing damage to neural cells but also of preventing and treating diseases caused by cognitive impairment.

Abstract: A method of fabricating a flash memory includes forming a first oxide film over a semiconductor substrate, forming a metal film over the first oxide film, forming a photoresist pattern on the metal film, etching the metal film using the photoresist pattern as a mask and forming a metal film pattern, forming a second oxide film overlying the metal film pattern, and heat-treating the first and second oxide films at high temperature and processing the metal film pattern using metal oxide crystallization.

Abstract: A method of fabricating a flash memory includes forming a first oxide film over a semiconductor substrate, forming a metal film over the first oxide film, forming a photoresist pattern on the metal film, etching the metal film using the photoresist pattern as a mask and forming a metal film pattern, forming a second oxide film including the metal film pattern, and heat-treating the first and second oxide films at high temperature and processing the metal film pattern using metal oxide crystallization.

Abstract: The present invention relates to a process for preparing haptens for immunoassay of phosphorothioate pesticides, which comprises the steps of reacting O-methyl(ethyl) dichlorothiophosphate with a phenolic compound to obtain O-methyl(ethyl) O-aryl chlorothiophosphate, and reacting the O-(methyl)ethyl O-aryl chlorothiophosphate thus obtained with aminocarboxylic acid to give desired haptens. In accordance with the present invention, haptens having a structure of O-methyl(ethyl) O-aryl N-(carboxyalkyl)phosphoramidothioate or O-methyl(ethyl) O-aryl N-alkyl-N-(carboxyalkyl)phosphoramidothioate can be simply prepared with a high yield by employing two-step processes in a cost-efficient manner.

Abstract: The present invention relates to a process for preparing haptens for immunoassay of phosphorothioate pesticides, which comprises the steps of reacting O-methyl(ethyl) dichlorothiophosphate with a phenolic compound to obtain O-methyl(ethyl) O-aryl chlorothiophosphate, and reacting the O-(methyl)ethyl O-aryl chlorothiophosphate thus obtained with aminocarboxylic acid to give desired haptens. In accordance with the present invention, haptens having a structure of O-methyl(ethyl) O-aryl, N-(carboxyalkyl)phosphoramidothioate or O-methyl(ethyl) O-aryl N-alkyl-N-(carboxyalkyl)phosphoramidothioate can be simply prepared with a high yield by employing two-step processes in a cost-efficient manner.